Cardiac stem cells for myocardial regeneration: promising but not ready for prime time.

Autor: Lader J; Department of Medicine, Leon H. Charney Division of Cardiology, New York University, School of Medicine, 522 1st Ave., New York, NY 10016, United States., Stachel M; Department of Medicine, Leon H. Charney Division of Cardiology, New York University, School of Medicine, 522 1st Ave., New York, NY 10016, United States., Bu L; Department of Medicine, Leon H. Charney Division of Cardiology, Department of Cell Biology, The Helen L. and Martin S. Kimmel Center for Stem Cell Biology, New York University, School of Medicine, 522 1 st Ave., Smilow Bldg Rm 804, New York, NY 10016, United States. Electronic address: lei.bu@med.nyu.edu.
Jazyk: angličtina
Zdroj: Current opinion in biotechnology [Curr Opin Biotechnol] 2017 Oct; Vol. 47, pp. 30-35. Date of Electronic Publication: 2017 Jun 04.
DOI: 10.1016/j.copbio.2017.05.009
Abstrakt: Remarkable strides have been made in the treatment of ischemic heart disease in decades. As the initial loss of cardiomyocytes associated with myocardial infarction serves as an impetus for myocardial remodeling, the ability to replace these cells with healthy counterparts would represent an effective treatment for many forms of cardiovascular disease. The discovery of cardiac stem cells (that can differentiate into multiple lineages) highlighted the possibility for development of cell-based therapeutics to achieve this ultimate goal. Recent research features cardiac stem cell maintenance, proliferation, and differentiation, as well as direct reprogramming of various somatic cells into cardiomyocytes, all within the context of the holy grail of regeneration of the injured heart. Much work remains to be done, but the future looks bright!
(Copyright © 2017 Elsevier Ltd. All rights reserved.)
Databáze: MEDLINE
Externí odkaz: